Clinical Trials Browser

Phase 1/2 × Leukemia × ulocuplumab × Clear all

NCT02305563 2021-09-16

An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase 1/2 Terminated

70 enrolled 36 charts

Other hematologic neoplasm

Leukemia